Skip Ribbon Commands
Skip to main content
# Comments with Link
No presence informationi:0#.f|aaccmembershipprovider|16427510/21/2014 3:53 PMSpecial Populations 
October 20142014Man Khun Chan0Approved
No presence informationi:0#.f|aaccmembershipprovider|16427510/7/2014 12:55 PMManagement/Medical Informatics 
October 20142014Linnea Baudhuin, PhD, DABMG
No presence informationi:0#.f|aaccmembershipprovider|1642759/23/2014 12:36 PMClinical Translational Science/Proteomics; Diabetes/Endocrinology; Management/Medical Informatics; Special Populations 
September 20142014Ann M. Gronowski, PhD, DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|1642759/9/2014 1:46 PMGovernment Affairs/Patient Safety; Management/Medical Informatics 
September 20142014Mario Plebani
No presence informationi:0#.f|aaccmembershipprovider|1642758/26/2014 2:36 PMManagement/Medical Informatics 
August 20142014Christine Snozek
No presence informationi:0#.f|aaccmembershipprovider|1642758/13/2014 10:05 AMCVD/Markers/Risk Factors; Diabetes/Endocrinology 
August 20142014Elizabeth Selvin
No presence informationi:0#.f|aaccmembershipprovider|1642757/15/2014 3:47 PMGovernment Affairs/Patient Safety; Instrumentation/Technology; Management/Medical Informatics 
July 20142014Darci Block, PhD, DABCC
No presence informationi:0#.f|aaccmembershipprovider|1642757/1/2014 8:59 AMManagement/Medical Informatics 
July 20142014Dina Greene, PhD
No presence informationi:0#.f|aaccmembershipprovider|1642756/17/2014 1:05 PMGovernment Affairs/Patient Safety; Management/Medical Informatics 
June 20142014Dan Scungio, MT (ASCP), SLS, CQA (ASQ)
No presence informationi:0#.f|aaccmembershipprovider|1642756/4/2014 9:17 AMGovernment Affairs/Patient Safety; Management/Medical Informatics 
June 20142014Michael Laposata, M.D., Ph.D.
No presence informationi:0#.f|aaccmembershipprovider|1642755/20/2014 8:53 AMInstrumentation/Technology; Management/Medical Informatics; Molecular Pathology and Genetics; POC Testing 
May 20142014Patricia M. Jones, PhD, DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|1642754/30/2014 1:50 PMCase Study; Management/Medical Informatics 
April 20142014James S. Hernandez, M.D., M.S.
No presence informationi:0#.f|aaccmembershipprovider|1642754/15/2014 11:52 AMCancer and Tumor Markers; Clinical Translational Science/Proteomics; Special Populations 
April 20142014Dr. Wendy Alderton, Chief Scientific Officer, Abcodia Ltd, UK
No presence informationi:0#.f|aaccmembershipprovider|1642754/1/2014 1:36 PMInstrumentation/Technology; Diabetes/Endocrinology 
April 20142014Dustin Bunch
No presence informationi:0#.f|aaccmembershipprovider|1642753/18/2014 2:27 PMInstrumentation/Technology; POC Testing; Special Populations 
March 20142014Xuan Mu, PhD
No presence informationi:0#.f|aaccmembershipprovider|1642752/21/2014 3:16 PMCase Study; Molecular Pathology and Genetics; Renal/GI/Hepatic; Special Populations; TDM/Toxicology 
February 20142014Danyel Tacker
No presence informationi:0#.f|aaccmembershipprovider|1642751/24/2014 11:12 AMCancer and Tumor Markers; Case Study; CVD/Markers/Risk Factors; TDM/Toxicology 
January 20142014Olaia Rodriguez Fraga
No presence informationi:0#.f|aaccmembershipprovider|16427512/31/2013 11:43 AMInstrumentation/Technology; Renal/GI/Hepatic; Special Populations 
December 20132013Angela M. Ferguson, Ph.D., DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|16427512/20/2013 2:03 PMImmunology/Infectious Disease ; New/Other Disease Markers  
December 20132013Gregg Wallis, PhD, CMgr.
No presence informationi:0#.f|aaccmembershipprovider|16427512/4/2013 3:04 PMCVD/Markers/Risk Factors; New/Other Disease Markers  
December 20132013Rojeet Shrestha, MS
No presence informationi:0#.f|aaccmembershipprovider|16427511/19/2013 4:32 PMNew/Other Disease Markers ; Renal/GI/Hepatic; Special Populations 
November 20132013Marie Browne, PhD
No presence informationi:0#.f|aaccmembershipprovider|16427510/30/2013 2:34 PMSpecial Populations; Diabetes/Endocrinology 
October 20132013Victoria Bevilacqua and Khosrow Adeli
No presence informationi:0#.f|aaccmembershipprovider|16427510/16/2013 1:17 PMCase Study; Diabetes/Endocrinology; Molecular Pathology and Genetics; New/Other Disease Markers ; Special Populations 
October 20132013Julia C. Drees, Ph.D., DABCC
No presence informationi:0#.f|aaccmembershipprovider|16427510/2/2013 2:05 PMGovernment Affairs/Patient Safety 
October 20132013Vince Stine, PhD
No presence informationi:0#.f|aaccmembershipprovider|1642759/20/2013 1:15 PMCase Study 
September 20132013William Winter, MD, DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|1642759/3/2013 11:42 AMCase Study 
September 20132013Sutirtha Chakraborty, MD & William Winter, MD, DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|1642758/21/2013 9:28 AMManagement/Medical Informatics 
August 20132013Patricia M. Jones, PhD, DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|1642758/7/2013 3:55 PMNutrition 
August 20132013Dr. Peggy Borum, PhD
No presence informationi:0#.f|aaccmembershipprovider|1642757/23/2013 11:08 AMMolecular Pathology and Genetics; Clinical Translational Science/Proteomics 
July 20132013Gregory Tsongalis, PhD
No presence informationi:0#.f|aaccmembershipprovider|1642757/9/2013 5:09 PMInstrumentation/Technology 
July 20132013Dina Greene, PhD
No presence informationi:0#.f|aaccmembershipprovider|1642756/26/2013 11:56 AMInstrumentation/Technology 
June 20132013Danyel H. Tacker
No presence informationi:0#.f|aaccmembershipprovider|1642756/11/2013 2:46 PMSpecial Populations 
June 20132013Alison Woodworth, PhD, DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|1642755/29/2013 10:23 AMCase Study 
May 20132013Neil Harris, MD, William Winter, MD, DABCC, FACB, & Lindsay A. Bazydlo, PhD
No presence informationi:0#.f|aaccmembershipprovider|1642755/14/2013 12:41 PMMolecular Pathology and Genetics 
May 20132013Patricia M. Jones, PhD, DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|1642754/30/2013 2:15 PMSpecial Populations 
April 20132013Callum G Fraser, PhD & William (Bill) A Bartlett, PhD, FRCPath
No presence informationi:0#.f|aaccmembershipprovider|1642754/16/2013 2:17 PMCase Study; Diabetes/Endocrinology 
April 20132013William E. Winter, MD; Roger L. Bertholf, Ph.D.
No presence informationi:0#.f|aaccmembershipprovider|1642754/2/2013 2:52 PMCase Study; TDM/Toxicology
April 20132013William E. Winter, MD; Lindsay Bazydlo, PhD, and Neil S. Harris, MD
No presence informationi:0#.f|aaccmembershipprovider|1642753/19/2013 3:55 PMSpecial Populations; New/Other Disease Markers  
March 20132013Michael J. Bennett Ph.D., FRCPath, DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|1642753/5/2013 9:32 AMCase Study; Molecular Pathology and Genetics 
March 20132013William E. Winter, MD; Lindsay Bazydlo, PhD, and Neil S. Harris, MD
No presence informationi:0#.f|aaccmembershipprovider|1642752/19/2013 11:55 AMInstrumentation/Technology; Management/Medical Informatics 
February 20132013Christine Snozek, PhD, DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|1642752/5/2013 4:45 PMCase Study; Instrumentation/Technology 
February 20132013Sutirtha Chakraborty, MD & William Winter, MD, DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|1642751/22/2013 2:01 PMCVD/Markers/Risk Factors 
January 20132013Verena Gounden, MBChB, FCP, MMed and Zhen Zhao, PhD, DABCChttp://
No presence informationi:0#.f|aaccmembershipprovider|1642751/8/2013 2:05 PMPOC Testing 
January 20132013Nichole Korpi-Steiner, PhD, DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|16427512/26/2012 4:11 PMManagement/Medical Informatics 
December 20122012Stanley F. Lo, Ph.D., DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|16427512/11/2012 11:48 AMManagement/Medical Informatics 
December 20122012Douglas F. Stickle, PhD, DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|16427511/27/2012 10:19 AMDiabetes/Endocrinology 
November 20122012William Winter, MD, DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|16427511/13/2012 1:34 PMCVD/Markers/Risk Factors 
November 20122012James H. Nichols, PhD, DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|16427510/31/2012 12:26 PMCase Study; Renal/GI/Hepatic 
October 20122012Dr. Sutirtha Chakraborty, MD and Dr. William Winter, MD
No presence informationi:0#.f|aaccmembershipprovider|16427510/16/2012 10:06 AMDiabetes/Endocrinology 
October 20122012William E. Winter, MD
No presence informationi:0#.f|aaccmembershipprovider|16427510/2/2012 10:21 AMManagement/Medical Informatics 
October 20122012Patricia M. Jones, PhD, DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|1642759/25/2012 9:29 AMClinical Translational Science/Proteomics; Instrumentation/Technology 
September 20122012Christopher Doern Ph.D
No presence informationi:0#.f|aaccmembershipprovider|1642759/18/2012 9:45 AMCase Study; Renal/GI/Hepatic 
September 20122012Dr Sutirtha Chakraborty, MD and Dr William Winter, MD
No presence informationi:0#.f|aaccmembershipprovider|1642759/11/2012 9:50 AMRenal/GI/Hepatic 
September 20122012Ioannis Papassotiriou, PhD
No presence informationi:0#.f|aaccmembershipprovider|1642759/4/2012 10:04 AMCVD/Markers/Risk Factors 
September 20122012Niel Harris, MD
No presence informationi:0#.f|aaccmembershipprovider|844588/28/2012 9:58 AMManagement/Medical Informatics 
August 20122012M. Laura Parnas, PhD, DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|844588/21/2012 10:27 AMManagement/Medical Informatics 

1. Hoffmann RG, Waid ME. The “average of normals” method of quality control. Am J Clin Pathol 1965;43:134-41.

2. Cembrowski GS, Chandler EP, Westgard JO.  Assessment of “Average of Normals” Quality Control Procedures and Guidelines for Implementation. Am J Clin Pathol 1984; 81: 492-9

August 20122012Mark Cervinski, PhD, DABCC
No presence informationi:0#.f|aaccmembershipprovider|844588/14/2012 9:56 AMDiabetes/Endocrinology; Case Study 
August 20122012William E. Winter, MD, Lindsay Bazydlo, PhD, Neil S. Harris, MD
No presence informationi:0#.f|aaccmembershipprovider|844588/7/2012 10:23 AMDiabetes/Endocrinology; Case Study 

[1]  Alonso N, Granada ML, Lucas A, Salinas I, Reverter J, Oriol A, Sanmarti A.
Evaluation of two replacement regimens in primary adrenal insufficiency patients. effect on clinical symptoms, health-related quality of life and biochemical parameters. J Endocrinol Invest. 2004 May;27(5):449-54.

[2]  Jeffcoate W. Assessment of corticosteroid replacement therapy in adults with adrenal insufficiency. Ann Clin Biochem. 1999 Mar;36 ( Pt 2):151-7.

[3] Burch WM. Urine free-cortisol determination. A useful tool in the management of chronic hypoadrenal states. JAMA. 1982 Apr 9;247(14):2002-4.


August 20122012William E. Winter, MD and Roger L. Bertholf, PhD
No presence informationi:0#.f|aaccmembershipprovider|844587/31/2012 5:49 PMManagement/Medical Informatics 
July 20122012Patti Jones, PhD, DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|844587/24/2012 11:17 AMCase Study; Instrumentation/Technology 
July 20122012William E. Winter, MD and Roger L. Bertholf, PhD
No presence informationi:0#.f|aaccmembershipprovider|844587/18/2012 5:35 PMGovernment Affairs/Patient Safety 


1. Stark L. Behind Closed Doors, IRBs and the Making of Ethical Research, University of Chicago Press, Chicago, 2012.

2. Keiger D., De Pasquale S. Trials & tribulation, Johns Hopkins Magazine, vol. 54, No. 1, February 2002.

3. London A., Kimmelman J., Carlisle B. Rethinking research ethics: The case of postmarketing trials, Science 336, 544-45, 2012. ​
July 20122012Doug Dix, PhD, DABCC, FACB
No presence informationi:0#.f|aaccmembershipprovider|844587/10/2012 9:48 AMSpecial Populations; TDM/Toxicology MSN coverage of positive drug tests in newbornsLocal North Carolina news coverage
July 20122012Steve Cotten, PhD and Catherine Hammett-Stabler, PhD
No presence informationi:0#.f|aaccmembershipprovider|844587/2/2012 3:39 PM Dina Greene, PhD, DABCC and Amy Pyle, PhD, DABCC
July 20122012Dina Greene, PhD, DABCC and Amy Pyle, PhD, DABCCDina Greene, PhD, DABCC and Amy Pyle, PhD, DABCC1Approved
No presence informationi:0#.f|aaccmembershipprovider|844586/26/2012 9:46 AMInstrumentation/Technology Pamela Steele, PhD


1. Miller, WG and Meyers, GL., NACB Blog (4/12/2011)










June 20122012Pamela Steele, PhDPamela Steele, PhD0Approved
No presence informationi:0#.f|aaccmembershipprovider|844586/19/2012 9:02 AMManagement/Medical Informatics Pamela Banning, MT(ASCP)cm, PMP
June 20122012Pamela Banning, MT(ASCP)cm, PMPPamela Banning, MT(ASCP)cm, PMP1Approved
No presence informationi:0#.f|aaccmembershipprovider|1377566/12/2012 8:58 AMCase Study; Diabetes/Endocrinology William E. Winter, MD, and Roger L. Bertholf, PhD
June 20122012William E. Winter, MD, and Roger L. Bertholf, PhDWilliam E. Winter, MD, and Roger L. Bertholf, PhD0Approved
No presence informationi:0#.f|aaccmembershipprovider|1377566/5/2012 8:39 AMPOC Testing; Instrumentation/Technology Brad S. Karon, MD, PhD, FACB


1. Crit Care Med 2003:31:S715-20. Blood conservation in the intensive care unit.
2. Arch Intern Med 2011;171:1646-53. Diagnostic blood loss from phlebotomy and hospital-acquired anemia during acute myocardial infarction.
3. Heart and Lung 2010;39:217-25. Anemia and blood transfusion practices in the critically ill: A prospective cohort review.


June 20122012Brad S. Karon, MD, PhD, FACBBrad S. Karon, MD, PhD, FACB2Approved
No presence informationi:0#.f|aaccmembershipprovider|1377565/29/2012 9:40 AMManagement/Medical Informatics Gregory J. Buffone, PhD

May 20122012Gregory J. Buffone, PhDGregory J. Buffone, PhD1Approved
No presence informationi:0#.f|aaccmembershipprovider|1377565/22/2012 9:20 AMInstrumentation/Technology Larry J. Kricka DPhil, FACB, CSci, CChem, FRSC, FRCPath
May 20122012Larry J. Kricka DPhil, FACB, CSci, CChem, FRSC, FRCPathLarry J. Kricka DPhil, FACB, CSci, CChem, FRSC, FRCPath0Approved
No presence informationi:0#.f|aaccmembershipprovider|1377565/15/2012 9:10 AMRenal/GI/Hepatic Jack Zakowski, PhD, FACB


1. Myers, et al, Clin Chem 2006:52, 5-18.
2. Greenberg, et al, Clin Chem 2011:58, 391-401.
3. Levey, et al, Clin Chem 2007:53, 766-772.
4. National Kidney Disease Education Program, Working Group meeting 2011. 

5. Levey, et al, Ann Intern Med 2009:150, 604-612.
6. National Kidney Disease Education Program: Laboratory Evaluation.

7. National Kidney Disease Education Program: CKD and Drug Dosing: Information for Providers.

8. Schwartz, et al, J Am Soc Nephrol 2009:20, 629-637.
9. Grubb, et al, Clin Chem Lab Med 2010:48, 1619-1621.

May 20122012Jack Zakowski, PhD, FACBJack Zakowski, PhD, FACB0Approved
No presence informationi:0#.f|aaccmembershipprovider|1377565/8/2012 11:59 AMSpecial Populations Khosrow Adeli, PhD, FCACB, FACB, DABCC

​Caliper Project

Caliper Database

Colantonio DA, Kyriakopoulou L, Chan MK, et al: Closing the Gaps in Pediatric Laboratory Reference Intervals: A CALIPER Database of 40 Biochemical Markers in a Healthy and Multiethnic Population of Children. Clin Chem 2012 May;58(5):854-68.

May 20122012Khosrow Adeli, PhD, FCACB, FACB, DABCCKhosrow Adeli, PhD, FCACB, FACB, DABCC4Approved
No presence informationi:0#.f|aaccmembershipprovider|1377565/1/2012 9:08 AMCVD/Markers/Risk Factors Andrew Hoofnagle, MD, PhD


1. Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, Cheung MC, et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest. 2007;117:746-56.
2. Hoofnagle AN, Wu M, Gosmanova AK, Becker JO, Wijsman EM, Brunzell JD, et al. Low Clusterin Levels in High-Density Lipoprotein Associate With Insulin Resistance, Obesity, and Dyslipoproteinemia. Arterioscler Thromb Vasc Biol. 2010;30:2528-34.
3. Green PS, Vaisar T, Pennathur S, Kulstad JJ, Moore AB, Marcovina S, et al. Combined statin and niacin therapy remodels the high-density lipoprotein proteome. Circulation. 2008;118:1259-67.
4. Karlsson H, Leanderson P, Tagesson C, Lindahl M. Lipoproteomics I: Mapping of proteins in low-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics. 2005;5:551-65.
5. Peterson MM, Mack JL, Hall PR, Alsup AA, Alexander SM, Sully EK, et al. Apolipoprotein B Is an innate barrier against invasive Staphylococcus aureus infection. Cell Host Microbe. 2008;4:555-66.

May 20122012Andrew Hoofnagle, MD, PhDAndrew Hoofnagle, MD, PhD2Approved
No presence informationAACC\bgarman4/24/2012 8:25 AMCase Study William E. Winter, MD, and Roger L. Bertholf, PhD
April 20122012William E. Winter, MD, and Roger L. Bertholf, PhDWilliam E. Winter, MD, and Roger L. Bertholf, PhD6Approved
No presence informationAACC\bgarman4/17/2012 8:29 AMInstrumentation/Technology; Cancer and Tumor Markers; Diabetes/Endocrinology Alicia Algeciras-Schimnich, PhD


1. Algeciras-Schimnich A, Lasho MA, Ness KM, Cheryk LA, Grebe SK. Thyroid 2011; 21(7):813-4.
2. Spencer C, Petrovic I, Fatemi S. J Clin Endocrinol Metab. 2011 May;96(5):1283-91.
3. Hoofnagle AN, Becker JO, Wener MH, Heinecke JW.  Clin Chem. 2008;54(11):1796-804.


April 20122012Alicia Algeciras-Schimnich, PhDAlicia Algeciras-Schimnich, PhD0Approved
No presence informationAACC\bgarman4/10/2012 8:28 AMNutrition Kenneth Hoekstra, PhD, HCLD, FACB
April 20122012Kenneth Hoekstra, PhD, HCLD, FACBKenneth Hoekstra, PhD, HCLD, FACB2Approved
No presence informationAACC\bgarman4/3/2012 8:31 AMDiabetes/Endocrinology William E. Winter, MD
April 20122012William E. Winter, MDWilliam E. Winter, MD0Approved
No presence informationAACC\bgarman3/27/2012 9:34 AM Christopher McCudden, PhD, DABCC, FACB
March 20122012Christopher McCudden, PhD, DABCC, FACBChristopher McCudden, PhD, DABCC, FACB0Approved
No presence informationAACC\bgarman3/20/2012 9:21 AMTDM/Toxicology Roger L. Bertholf, PhD, and William E. Winter, MD


 1. Baselt, RC. Disposition of Toxic Drugs and Chemicals in Man. Seventh Edition. 2004. Biomedical Publications, Foster City, CA.





March 20122012Roger L. Bertholf, PhD, and William E. Winter, MDRoger L. Bertholf, PhD, and William E. Winter, MD0Approved
No presence informationAACC\bgarman3/13/2012 8:22 AMManagement/Medical Informatics Darci Block, PhD, DABCC

1. Wians, FH.  To test or not to test? Opening Pandora’s Box.  Lab Medicine. 2004; 35:707.
2. Ritchie, JC.  NACBlog Is it Time to Remove the Stigma of LDT from Body Fluid Chemistry Assays? July 26, 2011
3. Clinical and Laboratory Standards Institute: Analysis of Body Fluids in Clinical Chemistry; Approved Guideline. Clinical and Laboratory Standards Institute, Wayne, PA, 2007, CLSI document C49-A (ISBN 1-56238-638-7) 
4. Chemistry and Toxicology CAP checklist. 2011

March 20122012Darci Block, PhD, DABCCDarci Block, PhD, DABCC0Approved
No presence informationAACC\bgarman3/6/2012 8:29 AMInstrumentation/Technology Frederick G. Strathmann, PhD, DABCC


1. Chace D, Mass spectrometry in the clinical laboratory. Chemical reviews, 2001. 101(2): p. 445-772.

2. Strathmann FG and Hoofnagle AN, Current and future applications of mass spectrometry to the clinical laboratory. Am J Clin Pathol, 2011. 136(4): p. 609-16.

September 6-7, 2012
Chicago, IL



March 20122012Frederick G. Strathmann, PhD, DABCCFrederick G. Strathmann, PhD, DABCC5Approved
No presence informationAACC\bgarman2/28/2012 8:28 AMInstrumentation/Technology; Molecular Pathology and Genetics Linnea M. Baudhuin, PhD, DABMG


1. Epstein RS, Moyer TP, Aubert RE,  et al. Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study). Journal of the American College of Cardiology 2010;55:2804-12.
2. Martin AM, Nolan D, Gaudieri S, et al. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Proceedings of the National Academy of Sciences of the United States of America 2004;101:4180-5.
3. Nissen SE. Pharmacogenomics and clopidogrel: irrational exuberance? JAMA 2011;306:2727-8.
4. Holmes MV, Perel P, Shah T, et al. CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis. JAMA 2011;306:2704-14.
5. Topol EJ, Teirstein PS, Price M, et al. 2011.

NACB Laboratory Medicine Practice Guideline on Pharmacogenomics
NACB Laboratory Medicine Practice Guideline on Pharmacogenetics

February 20122012Linnea M. Baudhuin, PhD, DABMGLinnea M. Baudhuin, PhD, DABMG0Approved
No presence informationAACC\bgarman2/21/2012 8:44 AMTDM/Toxicology Uttam Garg, PhD, DABCC, DABFT, FACB


  1. Garg U, Ferguson AM. Alternate specimens for drugs-of-abuse testing: preanalytical and interpretative considerations. In Clinical Toxicology Testing: A Guide for laboratory Professionals 2012. Eds M Barbarajean, MG Bissell, TC Kwong, AHB Wu, CAP Press, pp 71-80.
  3. Lo Muzio L, Falaschini S, Rappelli G,  et al. Saliva as a diagnostic matrix for drug abuse. Int J Immunopathol Pharmacol 2005;18:567-73.
  5. Gambelunghe C, Rossi R, Ferranti C, Bacci M. Hair analysis by GC/MS/MS to verify abuse of drugs. J Appl Toxicol 2005;25:205-11.
  7. Dolan K, Rouen D, Kimber J. An overview of the use of urine, hair, sweat and saliva to detect drug use. Drug Alcohol Rev 2004;23:213-7.













February 20122012Uttam Garg, PhD, DABCC, DABFT, FACBUttam Garg, PhD, DABCC, DABFT, FACB1Approved
No presence informationAACC\bgarman2/14/2012 8:25 AMInstrumentation/Technology; Special Populations Donald H. Chace, PhD, MSFS, FACB
February 20122012Donald H. Chace, PhD, MSFS, FACBDonald H. Chace, PhD, MSFS, FACB14Approved
No presence informationAACC\bgarman2/7/2012 8:51 AMManagement/Medical Informatics; Government Affairs/Patient Safety Gregory J. Buffone, PhD
February 20122012Gregory J. Buffone, PhDGregory J. Buffone, PhD1Approved
No presence informationAACC\bgarman1/31/2012 8:28 AMInstrumentation/Technology; POC Testing Douglas F. Stickle, PhD, DABCC, FACB


1. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol. 2005;27:81-90.

2. Hartert H. [Thrombelastography, a method for physical analysis of blood coagulation.] Z Gesamte Exp Med 1951;117:189-203.

3. Kitchen DP, Kitchen S, Jennings I, Woods T, Walker I. Quality assurance and quality control of thromboelastography and rotational thromboelastometry: the UK NEQAS for blood coagulation experience. Semin Thromb Hemost 2010;36:757-63.

4. Chitlur M, Lusher J. Standardization of thromboelastography: values and challenges. Semin Thromb Hemost 2010;36:701-11.


January 20122012Douglas F. Stickle, PhD, DABCC, FACBDouglas F. Stickle, PhD, DABCC, FACB5Approved
No presence informationAACC\bgarman1/24/2012 8:28 AMMolecular Pathology and Genetics Patti Jones, PhD, and Jason Y. Park, MD

2012 AACC/AMP Molecular Pathology Course

January 20122012Patti Jones, PhD, and Jason Y. Park, MD Patti Jones, PhD, and Jason Y. Park, MD2Approved
No presence informationAACC\bgarman1/17/2012 10:12 AMCase Study William E. Winter, MD, and Roger Bertholf, PhD


[1] Luten M, Roerdinkholder-Stoelwinder B, Bost HJ, Bosman GJ.
Survival of the fittest?--survival of stored red blood cells after transfusion. Cell Mol Biol (Noisy-le-grand). 2004 Mar;50(2):197-203.
[2] Spencer DH, Grossman BJ, Scott MG. Red cell transfusion decreases hemoglobin A1c in patients with diabetes. Clin Chem. 2011 Feb;57(2):344-6.


January 20122012William E. Winter, MD, and Roger Bertholf, PhDWilliam E. Winter, MD, and Roger Bertholf, PhD3Approved
No presence informationAACC\bgarman1/10/2012 9:36 AMCVD/Markers/Risk Factors William E. Winter, MD


1. Greenland P, Knoll MD, Stamler J, et al. Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events. JAMA. 2003;290:891-7.

2. Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, Ellis SG, Lincoff AM, Topol EJ.Prevalence of Conventional Risk Factors in Patients With Coronary Heart Disease. JAMA. 2003;290:898-904.






January 20122012William E. Winter, MDWilliam E. Winter, MD2Approved
No presence informationAACC\bgarman1/3/2012 9:00 AMDiabetes/Endocrinology Julie Rosser, DO, and Ronald Whitley, PhD
January 20122012Julie Rosser, DO, and Ronald Whitley, PhDJulie Rosser, DO, and Ronald Whitley, PhD0Approved
No presence informationAACC\bgarman12/29/2011 8:20 AM Patricia Jones, PhD, DABCC, FACB
December 20112011Patricia Jones, PhD, DABCC, FACBPatricia Jones, PhD, DABCC, FACB1Approved
No presence informationAACC\bgarman12/20/2011 8:26 AMCase Study William E. Winter, MD, DABCC, FACB


1. Ermensa AAM, Vlasveldb LT, Lindemansc J. Significance of elevated cobalamin (vitamin B12) levels in blood. Clinical Biochemistry 36 (2003) 585–590

December 20112011William E. Winter, MD, DABCC, FACBWilliam E. Winter, MD, DABCC, FACB0Approved
No presence informationAACC\bgarman12/13/2011 9:22 AMDiabetes/Endocrinology; Case Study William E. Winter, MD, and Patti Jones, PhD

​1. Velloso LA, Kämpe O, Hallberg A, Christmanson L, Betsholtz C, Karlsson FA. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression. J Clin Invest. 1993 May;91(5):2084-90.

2. Scherbaum WA, Trischler G, Pfeiffer EF. Non-human primate pancreas as a substrate for the detection of islet-cell antibodies in human sera. Diabetes Res Clin Pract. 1989 Jun 20;7(1):1-5.

3. Bergerot I, Souchier C, Thivolet C. Heterogeneity of islet cell cytoplasmic antibodies and autoantibodies to glutamate decarboxylase in relatives of patients with type 1 (insulin-dependent) diabetes. C R Acad Sci III. 1993 Nov;316(11):1368-73.

4. 4. Colman PG, Nayak RC, Campbell IL, Eisenbarth GS. Binding of cytoplasmic islet cell antibodies is blocked by human pancreatic glycolipid extracts  Diabetes. 1988 May;37(5):645-52.

5. Winter WE, Schatz DA. Autoimmune markers in diabetes. Clin Chem. 2011 Feb;57(2):168-75.

December 20112011William E. Winter, MD, and Patti Jones, PhDWilliam E. Winter, MD, and Patti Jones, PhD0Approved
No presence informationAACC\bgarman12/6/2011 9:22 AMCase Study William E. Winter, MD, DABCC, FACB

Additional Contributors to this blog post:

Neil S. Harris, MD, Associate Professor of Pathology

Lindsay Bazydlo, PhD, Assistant Professor Pathology








December 20112011William E. Winter, MD, DABCC, FACBWilliam E. Winter, MD, DABCC, FACB4Approved
No presence informationAACC\bgarman11/29/2011 8:42 AMGovernment Affairs/Patient Safety James Faix, MD
November 20112011James Faix, MDJames Faix, MD0Approved
No presence informationAACC\bgarman11/22/2011 6:57 AMCancer and Tumor Markers D. Robert Dufour, MD, FACB

1. Johansson J-E, Andrén O, Andersson S-O, Dickman PW, Holmberg L, Magnuson A, et al. Natural History of Early, Localized Prostate Cancer. JAMA: The Journal of the American Medical Association 2004;291:2713-2719.
2. Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, et al. Mortality Results from a Randomized Prostate-Cancer Screening Trial. New England Journal of Medicine 2009;360:1310-1319.
3. Schröder FH, Hugosson J, Roobol MJ, Tammela TLJ, Ciatto S, Nelen V, et al. Screening and Prostate-Cancer Mortality in a Randomized European Study. New England Journal of Medicine 2009;360:1320-1328.
4. Bill-Axelson A, Holmberg L, Filén F, Ruutu M, Garmo H, Busch C, et al. Radical Prostatectomy Versus Watchful Waiting in Localized Prostate Cancer: the Scandinavian Prostate Cancer Group-4 Randomized Trial. Journal of the National Cancer Institute 2008;100:1144-1154. 









November 20112011D. Robert Dufour, MD, FACBD. Robert Dufour, MD, FACB3Approved
No presence informationAACC\bgarman11/15/2011 9:16 AMDiabetes/Endocrinology; Instrumentation/Technology Steven Soldin, PhD, DABCC, FACB
November 20112011Steven Soldin, PhD, DABCC, FACBSteven Soldin, PhD, DABCC, FACB2Approved
No presence informationAACC\bgarman11/8/2011 8:35 AMDiabetes/Endocrinology; POC Testing David G. Grenache, PhD, DABCC, FACB


1. NACB. Evidenced-based Practice for Point-of-Care Testing. NACB Practice Guidelines. 2006.

2. When the test really counts. Consumer Reports 2003 February: 45-50.

3. Cervinski MA, Lockwood CM, Ferguson AM, Odem RR, Stenman UH, Alfthan H, et al. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy. Clin Chim Acta. 2009;406(1-2):81–85.

4. Sigel CS, Grenache DG. Detection of unexpected isoforms of human chorionic gonadotropin by qualitative tests. Clin Chem. 2007;53(5):989–990.

5. Gronowski AM, Cervinski M, Stenman U-H, Woodworth A, Ashby L, Scott MG. False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGbeta core fragment. Clin Chem. 2009;55(7):1389–1394.

6. Greene, D: What could be simpler than a pregnancy test? NACBLOG








November 20112011David G. Grenache, PhD, DABCC, FACBDavid G. Grenache, PhD, DABCC, FACB0Approved
No presence informationAACC\bgarman11/1/2011 8:26 AMCase Study; Diabetes/Endocrinology William E. Winter, MD, DABCC, FACB
November 20112011William E. Winter, MD, DABCC, FACBWilliam E. Winter, MD, DABCC, FACB21Approved
No presence informationAACC\bgarman10/25/2011 8:15 AMGovernment Affairs/Patient Safety Patricia M. Jones, PhD, DABCC, FACBOctober 20112011Patricia M. Jones, PhD, DABCC, FACBPatricia M. Jones, PhD, DABCC, FACB1Approved
No presence informationAACC\bgarman10/18/2011 8:19 AMCancer and Tumor Markers Joshua Bornhorst, PhD


1. Kyle RA, Rajkumar SV “Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma.” Leukemia. (2009); 23(1):3-9.
2. Fonesca et. al. “International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.” Leukemia. (2009); 23(12):2210-21.
3. Keren, D.F. “Heavy/Light-chain analysis of monoclonal gammopathies. Clin Chem, (2009); 55, 1606-1608.

















October 20112011Joshua Bornhorst, PhDJoshua Bornhorst, PhD1Approved
1 - 100Next